Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 800-765-8 | CAS number: 1424149-03-0
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study; well-performed and well-documented
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- sodium/triethanolamine 4-((2-hydroxyethyl)amino)-3-pentaproenyl-4-oxobutanoate
- EC Number:
- 800-765-8
- Cas Number:
- 1424149-03-0
- Molecular formula:
- C21H40NO4.1/2Na.1/2C6H15NO3
- IUPAC Name:
- sodium/triethanolamine 4-((2-hydroxyethyl)amino)-3-pentaproenyl-4-oxobutanoate
- Test material form:
- gas under pressure: refrigerated liquefied gas
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on mating procedure:
- After 14 days of treatment the both male and female, animals were paired (1:1) for a maximum of 14 days. The subsequent morning onwards the vaginal smears of females were checked to confirm the evidence of mating. After the confirmation of the mating, females were separated and housed individually.
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 28 days for males, up to 54 days for females
- Frequency of treatment:
- once per day
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 100, 250, 750 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- piloerection, nasal discharge, eye closure at 250 and 750 mg/kg bw
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- only reproduction organs investigated
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 750 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No significant systemic effect up to highest applied dose. No effect on the reproduction organ and no effect on the reproduction performance.
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 750 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No effect found for all parameters related to developmental toxicity
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
No mortality occurred in the control or any of the dose groups during the treatment period of this study.
At 250 and 750 mg/kg/day, signs of discomfort such as pushing the head through the bedding material and salivation were observed throughout the study in males and females. Occasionally, piloerection, nasal discharge and eye closure were also observed.
Food consumption and body weight and body weight gain were not affected by the treatment with the test item.
Gross pathological examination of male and females at scheduled necropsy did not revealed any treatment-related findings.
Absolute and relative weight of uterus, ovaries, testis, epididymides and prostate were not affected by the treatment with the test item.
The histopathologic examination of male and female reproductive organs did not indicate any test item-related changes. Two females of the control group, one female treated at 100 mg/kg/day, two females treated at 250 mg/kg/day and one female treated at 750 mg/kg/day were found not to be pregnant at terminal sacrifice. As there was no dose relationship, this was not considered to be treatment-related.
The litter weight was not affected by the treatment with the test item either at birth or on postnatal day 4.
No treatment related effect was observed on the total number of pups born per litter, and on the sex ratio. No external findings and no gross abnormalities were observed in pups at necropsy.
Fertility, delivery and viability indexes were similar within the group and were not indicative of any effect of the test item. Precoital interval and duration of the gestation were also not affected by the treatment with the test item.
Mean number of corpora lutea and of implantation sites were not considered to be affected by the treatment with the test item. Incidence of pre- and post-implantation losses was also not affected by the treatment with the test item.
Litter size and sex ratio were not affected by the treatment with the test item either at birth or on PND 4. Gross necropsy of dead pups revealed no treatment-related findings.
Applicant's summary and conclusion
- Conclusions:
- The reproduction toxicity of the registration substance was investigated according to the Guideline OECD 421. The NOAEL of 750 mg/kg bw, corresponding to highest applied dose, was obtained for parental and for developmental effects.
- Executive summary:
The reproduction toxicity of the registration substance was investigated according to the Guideline OECD 421. The rats were treated via gavage at doses of 0, 100, 250, and 750 mg/kg bw.
At doses of 250 and 750 mg/kg bw signs of discomfort were observed but no severe clinical signs. No effects were observed in food consumption and body weight. Macroscopic and histopathologic parameters and evaluation of litter data did not induce any test item-related effect.
The NOAEL of 750 mg/kg bw was obtained for parental and for developmental effects.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
